Royal Bank Of Canada Has Lowered Expectations for Molina Healthcare (NYSE:MOH) Stock Price

Molina Healthcare (NYSE:MOH) had its target price cut by investment analysts at Royal Bank Of Canada from $248.00 to $218.00 in a report released on Friday, Marketbeat reports. The firm presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price points to a potential upside of 10.30% from the company’s current price.

A number of other research analysts have also recently commented on the company. Barclays lowered their price target on Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating on the stock in a report on Friday. UBS Group increased their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a report on Friday, May 22nd. Sanford C. Bernstein set a $286.00 price objective on shares of Molina Healthcare in a research report on Monday, July 13th. Robert W. Baird boosted their target price on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Truist Financial upped their target price on shares of Molina Healthcare from $205.00 to $250.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $203.38.

Molina Healthcare Trading Down 1.3%

Shares of MOH stock opened at $197.64 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.63 and a current ratio of 1.68. The stock has a fifty day simple moving average of $206.19 and a two-hundred day simple moving average of $177.02. The firm has a market capitalization of $10.30 billion, a PE ratio of -1,097.94 and a beta of 0.74. Molina Healthcare has a 52-week low of $121.06 and a 52-week high of $244.89.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating the consensus estimate of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business had revenue of $10.87 billion for the quarter, compared to the consensus estimate of $10.83 billion. During the same period in the previous year, the business earned $5.48 earnings per share. The business’s revenue was down 4.8% on a year-over-year basis. On average, analysts predict that Molina Healthcare will post 5.31 EPS for the current fiscal year.

Insider Buying and Selling

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Family Wealth Partners LLC bought a new stake in Molina Healthcare in the second quarter worth $298,000. Contravisory Investment Management Inc. bought a new position in Molina Healthcare during the second quarter valued at $89,000. Chemistry Wealth Management LLC lifted its position in Molina Healthcare by 52.5% during the second quarter. Chemistry Wealth Management LLC now owns 15,517 shares of the company’s stock valued at $3,549,000 after purchasing an additional 5,339 shares during the last quarter. Beacon Investment Advisory Services Inc. grew its stake in shares of Molina Healthcare by 13.3% in the 2nd quarter. Beacon Investment Advisory Services Inc. now owns 5,202 shares of the company’s stock worth $1,190,000 after buying an additional 609 shares in the last quarter. Finally, Aurora Investment Managers LLC. grew its stake in shares of Molina Healthcare by 118.9% in the 2nd quarter. Aurora Investment Managers LLC. now owns 38,576 shares of the company’s stock worth $8,822,000 after buying an additional 20,956 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare News Summary

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina Healthcare beat Q2 earnings expectations with EPS of $1.51, and lower operating expenses helped offset weaker premium revenue and softer investment income. The company also raised its 2026 EPS outlook, which supports the long-term earnings case. Article Title
• Positive Sentiment: Analysts still see some upside from current levels despite recent weakness, with Truist and RBC both saying the stock could rise into the low-to-mid $200s. Article Title
• Neutral Sentiment: Wall Street’s consensus recommendation remains “Hold,” suggesting analysts are not turning bullish yet, but are also not broadly negative on the name. Article Title
• Negative Sentiment: Revenue and membership trends remain a concern, and multiple reports said investors were disappointed by weaker premium revenue and softer guidance even after the earnings beat. Article Title
• Negative Sentiment: Market reaction has been negative because Molina warned about a smaller Obamacare footprint and ongoing pressure in its Medicaid/ACA businesses, which outweighed the earnings beat. Article Title

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.